Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here. byPallavi MadhirajuApril 27, 2025